DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Managing Temporomandibular Disorder (TMD) Symptoms

Not Applicable

Completed

Conditions: Temporomandibular Joint Disorders

Interventions: Drug: 20 mcg ethinyl estradiol and 100 mcg levonorgestrel
Behavioral: Self Management
Behavioral: Targeted Self Management

First Posted Date: 2005-10-12

Last Posted Date: 2011-07-11

Lead Sponsor: University of Washington

Target Recruit Count: 252

Registration Number: NCT00237042

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Effects of ASA on Prostate Tissue

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Drug: Aspirin
Drug: Placebo

First Posted Date: 2005-10-06

Last Posted Date: 2016-05-25

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT00234299

Locations: 🇺🇸
VA Puget Sound Health Care Service, Seattle, Washington, United States

IC14 Antibodies to Treat Individuals With Acute Lung Injury

Phase 2

Terminated

Conditions: Respiratory Distress Syndrome, Adult
Lung Diseases

First Posted Date: 2005-10-05

Last Posted Date: 2017-05-16

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT00233207

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

Phase 4

Completed

Conditions: Hepatitis B

Interventions: Drug: Hepsera
Drug: Hepsera and lamivudine

First Posted Date: 2005-09-30

Last Posted Date: 2007-11-15

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT00230477

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Health Behavior Feedback Study for Veterans With Hepatitis C

Phase 1

Completed

Conditions: Alcoholism
Alcohol Abuse
Hepatitis C
Liver Disease

Interventions: Behavioral: 3 session brief intervention with health behavior feedback
Other: treatment as usual

First Posted Date: 2005-09-29

Last Posted Date: 2007-11-30

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT00229580

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel

Phase 1

Completed

Conditions: Contraception

Interventions: Drug: Nestorone gel
Drug: Testosterone Gel

First Posted Date: 2005-09-29

Last Posted Date: 2014-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 140

Registration Number: NCT00229593

Locations: 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

Phase 1

Completed

Conditions: Recurrent Breast Cancer
Stage IV Ovarian Epithelial Cancer
Recurrent Non-small Cell Lung Cancer
Stage IV Breast Cancer
HER2-positive Breast Cancer
Recurrent Ovarian Germ Cell Tumor
Recurrent Ovarian Epithelial Cancer
Stage IV Non-small Cell Lung Cancer
Stage IV Ovarian Germ Cell Tumor

Interventions: Drug: ex vivo-expanded HER2-specific T cells
Biological: denileukin diftitox
Drug: cyclophosphamide
Other: flow cytometry
Other: immunoenzyme technique

First Posted Date: 2005-09-28

Last Posted Date: 2014-11-11

Lead Sponsor: University of Washington

Target Recruit Count: 8

Registration Number: NCT00228358

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: cisplatin
Drug: pemetrexed disodium
Procedure: adjuvant therapy
Procedure: therapeutic conventional surgery
Radiation: fludeoxyglucose F 18

First Posted Date: 2005-09-28

Last Posted Date: 2017-05-09

Lead Sponsor: University of Washington

Target Recruit Count: 25

Registration Number: NCT00227539

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Flutamide
Drug: Leuprolide Acetate

First Posted Date: 2005-09-22

Last Posted Date: 2018-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 102

Registration Number: NCT00223665

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

TRADE-Testosterone Replacement and Dutasteride Effectiveness

Phase 4

Completed

Conditions: Hypogonadism
Benign Prostatic Hyperplasia

Interventions: Drug: Dutasteride
Drug: Testosterone gel
Drug: Placebo dutasteride

First Posted Date: 2005-09-19

Last Posted Date: 2017-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 53

Registration Number: NCT00194675

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy